Tema ETFs’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.71M Buy
14,054
+7,302
+108% +$787K 0.1% 158
2026
Q2
$473K Buy
6,752
+580
+9% +$30K 0.02% 421
2026
Q1
$314K Buy
6,172
+28
+0.5% +$1.31K 0.02% 434
2025
Q4
$181K Buy
+6,144
New +$167K 0.01% 490
2025
Q1
– Sell
-9,475
Closed -$394K – 162
2024
Q4
$394K Buy
+9,475
New +$453K 0.16% 115

Other funds holding MRNA

Tema ETFs's MRNA Position: Q3 2026 in Review

Tema ETFs increased its Moderna (MRNA) stake by 108% in Q3 2026, buying an estimated $787K and bringing the position to 14,054 shares worth $2.71M. The position accounts for 0.1% of the portfolio, ranked #158.

Tema ETFs first reported a position in MRNA in Q4 2024 and has held it in 5 quarters since. 137 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

  • Tema ETFs held 14,054 shares of Moderna worth $2.71M as of Q3 2026.
  • Tema ETFs bought 7,302 Moderna shares in Q3 2026, an estimated $787K.
  • Moderna made up 0.1% of Tema ETFs's portfolio in Q3 2026, its #158 holding.
  • Tema ETFs first reported a position in Moderna in Q4 2024 and has held it in 5 quarters since.
  • 137 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.